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We characterize the expression pattern of aquaporin-6 in the mouse inner ear by RT-PCR and immunohistochemistry. Our data
show that in the inner ear aquaporin-6 is expressed, in both vestibular and acoustic sensory epithelia, by the supporting cells
directly contacting hair cells. In particular, in the Organ of Corti, expression was strongest in Deiters’ cells, which provide both
a mechanical link between outer hair cells (OHCs) and the Organ of Corti, and an entry point for ion recycle pathways. Since
aquaporin-6 is permeable to both water and anions, these results suggest its possible involvement in regulating OHC motility,
directly through modulation of water and chloride ﬂow or by changing mechanical compliance in Deiters’ cells. In further support
of this role, treating mice with salicylates, which impair OHC electromotility, dramatically reduced aquaporin-6 expression in the
inner ear epithelia but not in control tissues, suggesting a role for this protein in modulating OHCs’ responses.
1.Introduction
Salicylates are a class of nonsteroidal anti-inﬂammatory
drugs (NSAIDs) with analgesic, antipyretic,a n d
anti-inﬂammatory eﬀects that are known to induce
reversible hearing loss and tinnitus [1]. A rationale for
salicylate-induced hearing loss is the block of prestin,
the molecular motor of outer hair cells (OHC), through
competition with intracellular Cl− [2–4]. On the other hand,
the mechanism underlying salicylate-induced tinnitus is still
unclear, since in the cochlea these drugs, besides prestin [2],
also target other systems, among which several players in
the stress/inﬂammation pathways [1] .T h es t r e s sr e s p o n s e
aﬀects a large number of targets, among which AQPs [5], the
proteins forming water channels in biological membranes
[6–8]. Several AQPs have been found in the inner ear, each
with its distinct distribution [9–12], but so far only AQP4
is known to aﬀect hearing [13]. The distribution and role
of AQP6, however, are less clearly characterized, and may
be interesting, given the low permeability to water and high
permeability to anions (both increased by low pH) of this
isoform [14]. Therefore, the function of AQP6 could be that
of regulating the ﬂow of anions rather than water, possibly
aﬀecting the behavior of outer hair cells (OHCs), which are
very sensitive to Cl− modulation [15]. Previous ﬁndings
show that AQP6 is expressed in human and rat inner ear,
but the protein localization is still controversial [9, 11, 12],
possiblyduetospeciesdiﬀerences,whichhavebeenobserved
forotheraquaporins[16,17].Whereasinvestibularepithelia
AQP6 was found in the apical part of supporting cells both
in human [9]a n dr a t[ 11] in the cochlea AQP6 has been
detected in the human Organ of Corti [9]b u tn o ti n
the rat Organ of Corti [11]. In agreement with AQP6
localization in other tissues, AQP6 immunoreactivity in
the rat ear appeared limited to intracellular structures,
with a negligible labeling in the plasma membranes
[11].
In the present paper, we studied AQP6 mRNA expression
in the mouse inner ear and its regulation by aspirin, by per-
forming semiquantitative reverse transcription/polymerase
chain reaction (RT-PCR), real time RT-PCR (qRT-PCR),
immunoblotting and immunohistochemistry.2 Journal of Biomedicine and Biotechnology
Table 1: Primer sequences used for semiquantitative and real time reverse transcription/polymerase chain reaction (RT-PCR).
Gene Primer sequences Size (bp) References Accession number
β-actin∗ Forward 5 -CAGATCATGTTTGAGACCTT-3  509 [18]N M 007393
Reverse 5 -CGGATGTCMACGTCACACTT-3 
AQP1 Forward 5 -TGCGTTCTGGCCACCACTGAC-3  327 [19]N M 007472
Reverse 5 -GATGTCGTCAGCATCCAGGTC-3 
AQP2 Forward 5 -GTTGCCATGTCTCCTTCCTT-3  441 This study NM 009699
Reverse 5 -GGAACAGCAGGTAGTTGTAG-3 
AQP4 Forward 5 -TTTCAAAGGAGTCTGGACTC-3  383 [20]N M 009700
Reverse 5 -TTCCATGAACCGTGGTGACT-3 
AQP6 Forward 5 -CTGCCATGATTGGAACCTCT-3  309 This study NM 175087
Reverse 5 -CTGTGTCCTCAGAGTTTGTC-3  DQ 826418
AQP6a-b Forward 5 -ACTGGCTGTTCCATGAACCC-3  727 (a), [14]N M 175087
Reverse 5 -AGGAAGTGGCCAGGAGGTACT-3  364 (b) DQ 826418
AQP7 Forward 5 -TTTGCAGGCGGAGACCTGTT-3  437 [21]N M 007473
Reverse 5 -CTCTGAGGATCCTGTGGTAT-3 
∗In real time RT-PCR experiments β-actin primers were Mm Actb 2 SG, QuantiTect Primer Assay QT01136772, Qiagen. AQP6a-b, aquaporin-6 variants a
and b. (a) and (b): AQP6 variant a and variant b.
2. Methods
2.1. Animals. C57BL6 mice (20–25 days old) were housed at
the animal facility of the Department of Physiology, section
of General Physiology, University of Pavia, cared for and
sacriﬁced according to the current European legal Animal
Practice requirements.
2.2. Salicylate Treatment. After treatment with saline (i.p.,
for 3 days) (controls) or aspirin (200mg/kg/day for 3 days,
i.p.) at least 4 animals for each condition in each experiment,
the mice were sacriﬁced 3 hours (treatment) or 24 hours
(recovery) after the last injection and processed for RNA
isolation or immunolocalization.
2.3. RNA Isolation and Semiquantitative RT-PCR. Total RNA
was extracted from the inner ear of at least 4 mice for
each condition (saline or aspirin) using the QIAzol Lysis
Reagent(QIAGEN,Italy).SinglecDNAwassynthesizedfrom
RNA (1μg) using random hexamers and M-MLV Reverse
Transcriptase (Invitrogen S.R.L., Italy). Speciﬁc primers for
mouse β-actin and for AQPs were synthesized based on their
published sequences (Table 1).
cDNAampliﬁcation wasperformedbyGoTaqFlexiDNA
Polymerase (Promega, Italy), as previously described [20].
The primers used for ampliﬁcation are listed in the Table 1.
The PCR protocol consisted of an initial denaturation of
5minat96 ◦C followed by 35 cycles of denaturation at 96◦C
for 30s annealing at 60◦C for 30s, and extension at 72◦C
for 30s. Reverse transcription was always performed both in
the presence (positive) or in the absence (negative control)
of reverse transcriptase enzyme. The RT-PCR reactions were
normalized using β-actin as an internal standard. First,
sequences of the AQP bands were checked by using the
Big dye terminator cycle sequencing kit (Applied Biosystem,
PE, USA). PCR products were separated on a 3% Nusieve
(2 : 1) gel agarose, stained with ethidium bromide, and
acquired with the Image Master VDS (Amersham Bio-
sciences Europe). Densitometric analysis of the bands was
performed by the Total Lab V 1.11 computer program
(Amersham)andtheresultswereexpressedasapercentageof
the AQP/β-actin densitometric ratio. The molecular weight
of the PCR products was compared with the DNA molecular
weight marker VIII (Roche Molecular Biochemicals, Italy).
2.4. qRT-PCR. qPCR was performed in triplicate using 1μg
cDNA, obtained as above indicated, and speciﬁc primers
(Table 1). MESA GREEN qPCR MasterMix Plus (Eurogen-
tec) was used according to the manufacturer instruction
and qPCR performed using Rotor Gene 6000 (Corbett).
The conditions were as follows: initial denaturation at
95◦C for 5min, 40 cycles of denaturation at 95◦Cf o r3 0s ;
annealing at 60◦C for 30s, and elongation at 72◦Cf o r
40s. The qRT-PCR reactions were normalized using β-actin
as housekeeping gene (Mm Actb 2 SG, QuantiTect Primer
Assay QT01136772, Qiagen). Melting curves were generated
to detect the melting temperatures of speciﬁc products
immediately after the PCR run. Relative mRNA levels were
determined by comparative quantitation (Corbett) and the
results expressed as fold change.Journal of Biomedicine and Biotechnology 3
2.5. Immunoblotting. Immunoblotting was performed as
previouslydescribed[22].Mousekidneyswerehomogenized
with an ULTRA-TURRAX homogenizer (IKA) in a solution
containing; 100mM NaCl, 1mM EDTA, 10mM Tris-HCl,
pH 6.8, and 0.1mg/mL PMSF, and treated as previously
described [23]. Lanes were loaded with 30μg proteins,
subjected to 12.5% SDS-polyacrilamide gel electrophoresis
and transferred to Hybond ECL nitrocellulose membranes
(Amersham) by electroelution. After 3hrs blocking with
Tris buﬀered saline (TBS) containing 5% nonfat dry milk
and 1% Triton X-100 (blocking solution), membranes were
incubated overnight with aﬃnity puriﬁed antibody to AQP6,
diluted 1 : 800 in blocking solution. Antibodies directed
against the C-terminal peptide of rat AQP6 with an addi-
tional N-terminal cysteine were prepared according to Yasui
etal. [24]. Membranes were washed and incubated for 1h
withperoxidase-conjugatedgoatantirabbitimmunoglobulin
G (1 : 120000 in blocking solution) (Amersham Biosciences
Europe, Italy). The bands were detected with an ECL
Advance western blotting detection system (Amersham
Biosciences Europe, Italy). Control experiments (not shown)
were performed, by preadsorbing the antibody with a 20-
fold molar excess of the immunizing peptide and by incu-
bating the blots with pre-immune rabbit serum. ChemiBlot
Molecular Weight Markers were used to accurately estimate
the molecular weight and as a positive control for the
immunoblot (Chemicon International, Inc., CA, USA).
2.6. Immunohistochemistry. C57BL6 mice were anesthetized
with 2-bromo-2-chloro-1,1,1-triﬂuoroethane and intracar-
dially perfused with acetate-buﬀered 4% (w/v) formalin.
Temporal bones were rapidly removed, postﬁxed for 1h,
decalciﬁed for at least 1 week in EDTA 4M and successively
processed into paraﬃn. Serial paraﬃns e c t i o n s( 5μm) were
brought to water and then washed with PBS. Sections were
successively treated with 3% (w/v) H2O2 for 20min at room
temperature (22◦C) to block endogenous peroxidases. After
washing for 5min with PBS, sections were blocked with 3%
(w/v) BSA in PBS for 60min at room temperature. Sections
were incubated overnight at 4◦C with rabbit anti-AQP6 [22]
diluted at 1 : 500 in PBS containing 1% BSA. After three 5-
minute washes with PBS containing 1% BSA, sections were
treated according to the Labeled Streptavidin Biotin (LSAB)
Method (Universal LSAB kit, Dako Italia S.p.A., Italy) and
washed three times with PBS containing 1% BSA. The
reaction was visualized by incubation with DakoCytomation
Liquid DAB (DakoCytomation, Milan, Italy). Sections were
counterstained with haematoxylin and mounted on DPX
(Merck Eurolab, Milan, Italy). Control experiments were
performed simultaneously using pre-immune serum or
omitting the primary antibody.
Immunostained slides were examined by light microsco-
py using an Olympus BX41 and the digital images captured
with the Nikon DS-Fi1 digital camera using Nis Element F
Imaging Software.
2.7. Statistics. All data are expressed as means ± SEM. The
signiﬁcance of the diﬀerences of the means was evaluated
with one-way ANOVA followed by Newman-Keuls’s Q test,
AQP1 327 bp
AQP2 441 bp
AQP4 383 bp
AQP6 309 bp
AQP7 437 bp
β−actin 509 bp
+ − + −
Saline Aspirin
Figure 1:Eﬀectofaspirinonaquaporin-1,-2,-4,-6,and-7(AQP1,
2, 4, 6, 7) mRNA expression in the mouse inner ear. Representative
semiquantitative RT-PCR with speciﬁc primers for AQP1, 2, 4,
6, 7 in control (saline) and aspirin treated mice (see Methods).
Reverse transcription was performed in the presence (+) or absence
(−) of reverse transcriptase enzyme. AQP mRNA expression was
normalized to β-actin. The 327, 441, 383, 309, 437, and 509bp
bands correspond to the AQP-3, -4, -8 and β-actin-speciﬁc PCR
products, respectively. Similar results were obtained from at least
four diﬀerent mouse RNA extracts.
MW RT+ RT−
727 bp mAQP6a
364 bp mAQP6b
Figure 2: RT-PCR analysis of AQP6 splice variants in the mouse
inner ear. Representative RT-PCR with speciﬁc primers designed to
amplify 727bp and 364bp fragments for mAQP6a and mAQP6b,
respectively, [14]. Reverse transcription was performed in the
presence (RT+) or absence (RT-) of reverse transcriptase enzyme.
Similar results were obtained from at least four diﬀerent mouse
RNA extracts.
or Student’s t test. All statistical tests were carried out with
GraphPad Prism 4.00, 2003.
3. Results
3.1. RT-PCR. Expression of AQPs in the mouse inner ear
was ﬁrst veriﬁed by semiquantitative RT-PCR after three
days of treatment with aspirin or saline (control condition).
The expression of each AQP was normalized to that of the
housekeeping gene β-actin. Single bands of the expected size4 Journal of Biomedicine and Biotechnology
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Figure 3: Eﬀect of aspirin treatment on aquaporin (AQP1, 2, 4, 6, 7) mRNA expression in mouse inner ear. Quantitative real-time RT-PCR
of total RNA was performed in mouse inner ear mRNA extract under three diﬀerent conditions: saline (controls), aspirin (mice treated for
3 days and sacriﬁced 3 hours after the last injection) recovery (treated for 3 days and sacriﬁced 24 hours after the last injection). Speciﬁc
primers for AQP1, 2, 4, 6, 7 were used and qRT-PCR performed as indicated (see Methods). The relative mRNA levels were determined
by comparative quantitation (Corbett), the values obtained were normalized to the corresponding β-actin level and the results expressed as
fold change. Results indicate that mRNA expression level of AQP6 was signiﬁcantly lower in aspirin treated mice. Bars represent the mean ±
S.E.M. of 4–8 diﬀerent experiments each from diﬀerent RNA extracts. ∗, P<. 05 versus saline and recovery (one-way ANOVA followed by
Newman-Keuls’s Q test).Journal of Biomedicine and Biotechnology 5
of cDNA fragments were ampliﬁed (327, 441, 383, 309, 437
and509bpforAQP1,2,4,6,7andβ-actin,resp.).Theresults
of agarose gel electrophoresis of representative PCR reaction
products are shown in Figure 1.N e g a t i v ec o n t r o l sw e r e
performed by omitting the reverse transcriptase. Only AQP6
mRNA expression was clearly aﬀected by aspirin treatment,
while other AQPs were unchanged (Figure 1). Densitometric
analysis of the bands showed that AQP6 transcript was
signiﬁcantly reduced (means ± S.E.M. of AQP6/β-actin
densitometric ratio): saline, 161 ± 15%; aspirin, 111 ± 13%
(∗P<. 043 Student’s t test).
Recently, Yasui and coworkers [14] found two AQP6
splice variants in the mouse kidney: AQP6a (similar to the
rat AQP6), and AQP6b, found also in the mouse cerebellum.
We performed RT-PCR using speciﬁc primers designed to
diﬀerentiate between the two variants as in [14]a n df o u n d
both variants expressed in the ear (Figure 2).
3.2. qRT-PCR. The eﬀect of aspirin treatment on the expres-
sion of AQP mRNAs in the mouse inner ear was then inves-
tigated by quantitative real time RT-PCR. Results showed
that aspirin treatment signiﬁcantly decreases AQP6 mRNA
expression (about 70%, Figure 3), while no signiﬁcant
changeswereobservedforAQP1,2,4and7transcriptsunder
this condition. Moreover, the results showed a signiﬁcant
recovery of mRNA AQP6 expression 24 hours after the
last treatment with aspirin (Figure 3). To investigate the
speciﬁcity of aspirin eﬀect, we checked AQP6 mRNA levels
in the kidney and in the small intestine. In these organs,
no signiﬁcant changes of AQP6 transcript expression were
observed: small intestine, 0.883 ± 0.001 (saline) and 0.791 ±
0.125 (aspirin); kidney, 1.01 ± 0.03 (saline) and 0.96 ± 0.09
(aspirin) (fold change; P>. 5, Student’s t test).
3.3. Immunoblotting. Immunoblots of mouse kidney
homogenates have been performed to test the antibody
used for immunohistochemistry. The results revealed the
expected bands (Figure 4), consistent with published data
[14].
3.4. Immunohistochemistry. Cellular localization of AQP6
was investigated with immunohistochemistry using aﬃnity-
puriﬁed antibodies against mouse and rat AQP6. AQP6 was
expressed in both cochlear (Figures 5(a), 5(c) and 6(a))a n d
vestibular (Figure 6(b)) epithelia, and in neuronal somata
in the spiral ganglion (Figure 5(b)); faint or no labelling
was noted in the stria vascularis (not shown). In the Organ
of Corti (Figure 5(a), 5(c)), labelling was most intense and
consistent in Deiters’ cells, which were labelled throughout
their length (Figure 5(a), 5(c)), and also present at inner
phalangealcellsandpillarsofCorti(Figure 5(a)).Controlsin
whichtheprimaryantibodywasreplacedbythepre-immune
serum show an absence of labelling (Figure 5(d)). No clear
labelling was observed in hair cells (Figure 5(a) and 5(c)).
In vestibular epithelia (Figure 6(b)), labelling was evident,
mainly in supporting cells.
After treatment with aspirin (see Methods), labelling
was strongly reduced or lost in both the Organ of Corti
(Figure 6(c)) and vestibular epithelia (Figure 6(d)). Reduc-
tion in ganglion cells was less evident (not shown).
14
28
42
55
68
82
(kDa) MW Kidney
Figure 4: AQP6 protein expression in mouse kidney homogenate.
Immunoblot of mouse kidney total homogenate was performed as
described (see Methods). Two bands of about 55 and 36kDa were
observed. Similar results were obtained from at least four separate
experiments. MW, molecular weight markers.
4. Discussion
In the present paper, we characterize for the ﬁrst time
the expression pattern of AQP6 in the mouse ear sensory
epithelia and its regulation by salicylates.
Our data agree with previous studies in human [9]a n d
rat [11] showing strong AQP6 expression in the supporting
cellsofvestibularepithelia.Inthecochlea,ontheotherhand,
our results disagree with previous localization in the rat,
where labelling was seen in the stria vascularis but not in
the organ of Corti. Although some discrepancies could be
ascribed to diﬀerences in species and antibodies used, it is
alsopossiblethatthediﬀerentlabellingobservedintheorgan
of Corti results from variations in the modulation set point
of expression, as our salicylate experiments show.
Our data show that AQP6 is expressed in the organ
of Corti, and particularly in Deiters’ cells. This pattern of
expression suggests a possible role for AQP6 in regulating
OHCelectromotility,whichinvolvesbothwaterandchloride
ﬂow, or in modulating Deiters’ cell stiﬀness, which would
aﬀect OHC action on basilar membrane movement [15].
In facts, AQP6 displays interesting properties, and it is
still debated whether its main function is that of an anion
channel, a water channel, or both [25]. Moreover, although
originally thought to be only intracellular [26], recent
data show that AQP6 can bind calmodulin with its N-
terminal domain [27], which is responsible for its subcellular
localization [26]. It is therefore possible that stimuli that
increase cytoplasmic Ca2+ (such as purinergic signalling
in Deiters’ cells [28]), induce AQP6 traslocation to the
plasmamembrane,similartowhatvasopressindoestoAQP2
[29].6 Journal of Biomedicine and Biotechnology
(a)
(b) (c)
(d)
OHC
OHC
DC
DC
Figure 5: Immunohistochemical localization of the aquaporin-6 protein in the mouse inner ear. Paraﬃn embedded cochlear sections were
labeledwithanti-AQP6antibody.InthecochleaAQP6stainingwasobservedintheOHCregion(a),especiallyinDeiters’cells(a),(c).Lower
signal was observed in inner phalangeal cells (a) and spiral ganglion (b). (c): higher magniﬁcation detail of the organ of Corti in the OHC
region. Thescheme on the right depicts the complex arrangement of Deiters’ cells (DC, brown) and outer hair cells (OHC, green). Nuclei are
shown in blue. The lighter apical part of Deiters’ cells is the terminal lamina, which was not labeled. Deiters’ cell stalk and body were instead
clearly labeled. Given the complex shape of these cells, it appears diﬃcult to localize AQP6 to cytoplasmic or membrane compartments.
Control sections treated with pre-immune serum show an absence of labelling (d). The micrographs are representative of four separate
experiments. Scale bar: 20μm( a ) ,( b ) ,( d ) ,1 0μm( c ) .
To further explore this role, we treated mice with
salicylates, which are known to impair OHC electromotility,
and observed variations in the expression of AQP6 after
treatment. AQP6 mRNA expression and protein labeling of
the organ of Corti are dramatically reduced after treatment
with aspirin. The reduction is quite rapid, being evident
already at 3hrs after the last day of treatment and reversed
24 hours after treatment has ended.Journal of Biomedicine and Biotechnology 7
(a) (b)
(c) (d)
Figure 6: Eﬀect of aspirin treatment on aquaporin-6 protein in the mouse inner ear. Mice were treated with saline (a), (b) and salicylate (c),
(d) as described in Methods. Same conditions as Figure 5. In both the organ of Corti (a), (c) and vestibular epithelia (b), (d), AQP6 labeling
was lost or strongly attenuated. In vestibular epithelia of saline treated mice, AQP6 was present, possibly in supporting cells. Inset in (b)
shows a 2.5× magniﬁcation of the region in the box displaying labeling of the apical part of the hair cell (above the nucleus in the inset) and
of the thin supporting cells (whose nuclei are deeper in the epithelium and therefore not in the inset). The micrographs are representative of
four separate experiments. Scale bar: 20μm ((a), (c)), 10μm ((b), (d)).
These results appear interesting because salicylates
are well known for their reversible ototoxic eﬀect but
the pathways through which they act are still largely unclear.
Since prestin and AQP6 appear to be expressed by diﬀerent
cell types, the link between their modulations may be
complex.
One possible link between OHC block and AQP6 down-
regulation in Deiters’ cells is COX-2. In fact, this enzyme has
been found to be involved in the downregulation of AQP2
in the kidney [30], and is expressed in Deiters’ cells, where
it is modulated by sound conditioning, possibly through
mechanically sensitive pathways [31]. This enzyme could
be modulated by salicylates (and by unknown physiological
processes) in vestibular epithelia as well (where neither
prestin nor motility are present), thus explaining AQP6
downregulation in these organs. Moreover, it is interesting
to note the absence of downregulation in small intestine and
in the kidney epithelia, suggesting the presence of diﬀerent
modulation mechanisms in diﬀerent organs.
5. Conclusions
In the present paper, we characterize the expression pattern
of AQP6 in the mouse inner ear sensory epithelia. Our data
show that AQP6 is expressed in the organ of Corti, and
in particular in Deiters’ cells. This suggests a possible role
for AQP6 in regulating OHC motility, through modulation
o fw a t e ra n dc h l o r i d eﬂ o wo ro fD e i t e r s ’c e l lm e c h a n i c a l
compliance.Tofurtherexplorethisrole,wetreatedmicewith
salicylates, which impair OHC electromotility, and observed
variations in the expression of AQP6 after treatment. AQP6
mRNA expression and protein labeling of the organ of
Corti are dramatically reduced already at 3 hrs after the
last day of treatment with aspirin. Similar reduction is
observed in vestibular epithelia, but not in control tissues
(smallintestineandkidney).TheseresultssuggestthatAQP6
downregulation is not due to motility/prestin-dependent
pathways, but may aﬀect OHCs’ ionic environment and/or
their mechanical response through changes in coupling to
the Organ of Corti.
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